Euclises

Euclises

Novel cox-2 inhibitors for the effective treatment of cancers in the lungs, colon, and pancreas.

HQ location
St. Louis, United States
Website
euclises.com
Launch date
Employees
2-10 people
Enterprise value
$5—7m
https://www.linkedin.com/company/euclises-pharmaceuticals-inc./
Authorizing premium user...